Jazz Hits Teva With Patent Suit Over Narcolepsy Drug

By Carla Baranauckas · August 29, 2024, 3:40 PM EDT

Teva Pharmaceuticals Inc. is infringing a patent for the narcolepsy drug Xywav, Jazz Pharmaceuticals Inc. said in a complaint filed in New Jersey federal court....

To view the full article, register now.

Documents

Case Information

Case Title

JAZZ PHARMACEUTICALS IRELAND LIMITED v. TEVA PHARMACEUTICALS, INC.

Case Number

2:24-cv-08785

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

August 27, 2024